Facebook
Twitter
LinkedIn
ForwardACRO Proton Therapy Symposium–Miami
ACRO Proton Therapy Symposium-Miami will provide proton therapy teams with a valuable and practical opportunity to explore future directions in proton therapy, the latest evidence-based proton treatment planning for specific diseases and disease sites, as well as strategies for patient selection and expanding access to proton therapy through cost-effective utilization and engagement with payors and government. International experts will review best practice proton therapy approaches to lymphoma and cancers of the head, neck, prostate, liver and the central nervous system including pediatric patient treatment. The setting and format allow physicians, physicists and dosimetrists to learn in a relaxed environment with plenty of opportunity for interaction with faculty and peers and exhibitors to expand the clinical knowledge base of proton therapy for cancer treatment.
Registration Fees: Please choose Register tab to process your registration.
| Attendee Type | Cost |
| Physician (ACRO member) | $349 |
| Physician (non-member) | $449 |
| Physicist (ACRO member) | $249 |
| Physicist (non-member) | $349 |
| Dosimetrist/Nurse/Radiation Therapists/Trainee or Fellow | $125 |
Target Audience
This clinical symposium is intended for physicians, physicists, and dosimetrists currently practicing, or planning to practice, proton therapy, or those who simply want to know more about this treatment modality to enhance professional competence.
Learning Objectives
- Implement the latest proton beam therapy techniques for cancers of the breast, head and neck, prostate, liver, lung, lymphoma, as well as adult and pediatric brain tumors.
- Describe the fundamental principles behind proton therapy treatment planning
- Examine the full clinical potential and benefits of proton beam therapy, and explore emerging therapies and future directions.
- Evaluate the latest evidence on pencil beam scanning methods and dose calculation algorithms.
- Identify the current limitations of proton beam therapy and explore innovative solutions currently in development.
- Describe methods to optimize patient selection, access in the community, and cost effectiveness of proton therapy.
SYMPOSIUM AGENDA
DAY 1 – Saturday, December 1 – 7:15 a.m. - 5 p.m.
7:15 a.m. Registration, Exhibits and Continental Breakfast
7:55 a.m. Welcome Remarks - James Welsh
Keynote Session: Proton Therapy: Past, Present, and Future
Moderator: Michael Chuong
8:00 a.m. The History and Evolution of Proton Therapy - Michael Chuong
8:20 a.m. Evidence Based Proton Therapy: Current Data, Enrolling Trials, and Future Directions – Charles Simone
8:40 a.m. Reduction of Secondary Cancers Using Proton Therapy - James Welsh
Proton Treatment Planning 101
Moderator: Mark Pancuch
9:00 a.m. Proton Treatment Planning: Dosimetry Perspective - Craig McKenzie
9:30 a.m. Proton Treatment Planning: Physics Perspective - Alonso Gutierrez
10:00 a.m. Question and Answer Panel
10:15 a.m. Break & Visit Exhibits
Liver
Moderator: Michael Chuong
10:30 a.m. Proton Therapy for Liver Cancer: Who, Why, and How - Michael Chuong
11:00 a.m. Treatment Planning Review: Liver - Fazal Khan
11:30 a.m. Avoiding Moving Targets: An Irrational Fear? - Mark Pankuch
12:00 p.m. Lunch & Visit Exhibits
Head and Neck/Reirradiation
Moderator: John Chang
1:00 p.m. Head and Neck Proton Therapy: Positively Improving the Therapeutic Ratio - John Chang
1:30 p.m. Treatment Planning Review: Head and Neck - Kevin Kirby
2:00 p.m. Clinical Outcomes and Treatment Planning for Proton Reirradiation: A New Chance of Cure - Charles Simone
Prostate (Moderator: James Welsh)
2:30 p.m. Reducing toxicity in prostate cancer patients using proton therapy - Marcio Fagundes
3:00 p.m. Break & Visit Exhibits
Patient Selection, Expanding Access, and Cost (Moderator: Michael Chuong)
3:15 p.m. The Importance of Clinical Research in Proton Therapy: Update from the Proton Collaborative Group - Charles Simone
3:45 p.m. Patient selection and cost-effective utilization of proton therapy - Mark Mishra
4:15 p.m. Developing proton therapy as a regional resource - Ben Wilkinson
4:45 p.m. Question and Answer Panel
5-7:00 p.m. MCI Tour and Reception
DAY 2 – Sunday, December 2 – 8 a.m.-12:45 p.m.
8:00 a.m. Registration, Exhibits and Continental Breakfast
CNS/Peds
Moderator: John Chang
8:30 a.m. Proton Therapy for Brain Tumors: Focusing on Neurocognition - Rupesh Kotecha
9:00 a.m. Take Your Best Shot: How Radiation Treatment Modality and Patient Selection Can Reduce Late Toxicities - Matthew Hall
9:30 a.m. Treatment Planning Review: Craniospinal Irradiation - David DeBlois
10:00 a.m. Break & Visit Exhibits
Thoracic/Lymphoma
Moderator: Charles Simone
10:15 a.m. Proton Therapy for Lung and Lymphoma - Brad Hoppe
10:45 a.m. Breast Cancer: Case Review and Patient Selection for Proton Therapy - Marcio Fagundes and Nancy Mendenhall
11:15 a.m. Treatment Planning Review: Breast - Kevin Greco
11:45 a.m.-12:45 p.m. Lunch and Adjourn
A limited number of rooms are available at the nearby Marriott hotels at the Baptist Health corporate rates.
$139* Miami Marriott Dadeland | 9090 S. Dadeland Blvd., Miami, Fla. 33156
$119* Courtyard Miami Dadeland | 9075 S. Dadeland Blvd., Miami, Fla. 33156
*Plus applicable taxes and hotel fees
These rates are not guaranteed and are available on a first-come first-served basis!
Reserve your room now to lock in these rates.
To book online, go to marriott.com/miadd Use Corporate/Promo code: B81
NOTE: On the “Enter your dates” page, under “Special Rates” select Corporate/Promo from the drop-down list of options, and enter the code, B81.
PLANNING COMMITTEE
John Han-Chih Chang, M.D.
Pediatric Radiation Oncologist
Head and Neck Radiation Oncologist
Vanderbilt University Medical Center
Nashville, Tennessee
Michael D. Chuong M.D.
Radiation Oncologist
Miami Cancer Institute
Miami, Florida
Craig McKenzie, CMD
Medical Dosimetrist
Miami Cancer Institute
Miami, Florida
Mark Pankuch, Ph.D.
Medical Physicist
Chicago Proton Center
Warrenville, Illinois
Charles B. Simone, II, M.D.
Radiation Oncologist
University of Maryland School of Medicine
Baltimore, Maryland
James S. Welsh, MD, MS, FACRO
Radiation Oncologist
Loyola University, Maywood, Illinois
Edward Hines, Jr., VA Hospital, Hines, Illinois
LOCAL AND VISITING FACULTY
David DeBlois, CMD
Medical Dosimetrist
Miami Cancer Institute
Miami, Florida
Marcio Fagundes, M.D.
Radiation Oncologist
Miami Cancer Institute
Miami, Florida
Kevin Greco, CMD
Medical Dosimetrist
Miami Cancer Institute, Miami, Florida
Alonso Gutierrez, Ph.D., MBA
Chief Physicist
Miami Cancer Institute
Miami, Florida
Matthew Hall, M.D.
Radiation Oncologist
Miami Cancer Institute
Miami, Florida
Brad Hoppe, M.D.
Radiation Oncologist
University of Florida Health Proton Therapy Institute
Jacksonville, Florida
Kevin Kirby, CMD
Medical Dosimetrist
Provision Center for Proton Therapy
Knoxville, Tennessee
Rupesh Kotecha, M.D
Radiation Oncologist
Miami Cancer Institute
Miami, Florida
Nancy Mendenhall, M.D.
Radiation Oncologist
University of Florida Health Proton Therapy Institute
Jacksonville, Florida
Mark Mishra, M.D.
Radiation Oncologist
University of Maryland School of Medicine
Baltimore, Maryland
Ben Wilkinson, M.D.
Radiation Oncologist
Provision Center for Proton Therapy
Knoxville, Tennessee
Disclosures
Non-faculty contributors and other individuals involved in the planning, development, review and editing of the symposium content have indicated that neither they nor their spouses/partners have relevant financial relationships.
All faculty members have indicated their presentations will not include off-label or unapproved usage.
The following faculty members have disclosed relevant financial relationships with commercial interest companies, and the CME Department has resolved potential conflicts of interest.
Marcio Fagundes, M.D., has indicated that he is a consultant for Augmenix, Inc.
Matthew D. Hall, M.D., MBA, has indicated that he is a member of the Speakers’ Bureau for Accuray.
Bradford S. Hoppe, M.D., has indicated that he is a consultant for Merck.
Rupesh Kotecha, M.D., has indicated that he is on the Speakers’ Bureau for Accuray, Elekta AB, Chrysalis Biotherapeutics, Inc., and Elsevier.
Mark Mishra, M.D., has indicated that he is on the Speakers’ Bureau for Varian and stock shareholder for GE and Adverum.
Craig McKenzie, CMD, has indicated that he is a stock shareholder for RaySearch.
J. Ben Wilkinson, M.D., has indicated that he is on the Speakers’ Bureau for Novocure, on the Advisory Board for Novocure and a consultant for Augmenix.
The following faculty members indicated that neither they nor their spouses/partners have relevant financial relationships with commercial interest companies.
John Han-Chih Chang, M.D.
Michael D. Chuong, M.D.
David DeBlois, CMD
Kevin Greco, CMD
Alonso N. Gutierrez, Ph.D., MBA
Fazal H. Khan, CMD
Kevin Kirby, CMD
Nancy Mendenhall, M.D.
Mark Pankuch, Ph.D.
Charles B. Simone, II, M.D.
James S. Welsh M.S., M.D., FACRO
Disclosure Policy and Disclaimer
Accreditation and Credits
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Baptist Health South Florida and the American College of Radiation Oncology. Baptist Health South Florida is accredited by the ACCME to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live educational activity for a maximum of 10.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology’s criteria for a self-assessment (SAM) activity and is designated for up to 4 SAM Credits toward the ABR Maintenance of Certification program. ACRO is a deemed provider of SA-CMEs for the ABR MOC program and qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program, April 21, 2015.
This activity has been approved for 10.5 credit hours by the Florida Boards of Medicine, Osteopathic Medicine, Nursing and by the Florida Council of Physician Assistants. 7.5 credits for the Saturday session (CE Broker #20-673346) and 3 credits for the Sunday session (CE Broker #20-673352). CE Broker Provider #50-182.
This activity has been approved for 10 credit hours by the Florida Council of Medical Physicists. 7 credits for the Saturday session (CE Broker #20-673346) and 3 credits for the Sunday session (CE Broker #20-673352). CE Broker Provider #50-182.
This activity has been approved for a maximum of 10.50 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
These activities have been approved for continuing education credits by the Florida Bureau of Radiation Control, Provider #3201106. 7.5 credits for the Saturday session (Course #21001457). 3.0 credits for the Sunday session (Course #21-001456).
This activity has been approved for 10.5 MDCB credits by the Medical Dosimetrist Certification Board.
Endorsed by 
Available Credit
- 10.50 AMA PRA Category 1 Credit™
- 10.50 General certificate of attendance
- 10.50 Nurse Practitioners
- 10.50 Florida Board of Nursing
Price
Required Hardware/Software
If you are attempting to register and see this message only, please check in the upper right hand corner for a shopping cart and click on it.
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.